alanine has been researched along with 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ang, C | 1 |
1 review(s) available for alanine and 3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea
Article | Year |
---|---|
Role of the fibroblast growth factor receptor axis in cholangiocarcinoma.
Topics: Alanine; Antineoplastic Agents; Bile Duct Neoplasms; Cholangiocarcinoma; Chromosome Aberrations; Drug Discovery; Gene Fusion; Humans; Molecular Targeted Therapy; Phenylurea Compounds; Protein Kinase Inhibitors; Pyrimidines; Receptor, Fibroblast Growth Factor, Type 2; Receptors, Fibroblast Growth Factor; Signal Transduction; Triazines | 2015 |